GSK’s ViiV Healthcare settles patent row with Gilead Sciences
USA – Viiv Healthcare, a specialist HIV company majority-owned by GlaxoSmithKline with Pfizer and...
Read More
Tag: ARVs
FDA approves extended dosing interval for ViiV HIV drug, cutting antiretroviral dosing by half
USA – The U.S. Food and Drug Administration has approved ViiV Healthcare’s HIV treatment...
Read More
Huge blow to Gilead’s and Merck’s HIV strategy as safety concerns mar once-weekly HIV drug combination
USA – Gilead Sciences, Inc. and Merck have temporarily suspended enrollment in a Phase 2...
Read More
Kenya to utilize Mobile app in medicines distribution as the country works to stabilize ARV supply
KENYA – Kenya has inked a deal with the private sector to roll out the use of a mobile...
Read More
LATEST DIGITAL MAGAZINE
